The gut microbiota metabolite butyrate mitigates MPTP / MPP + ‐induced Parkinson's disease by inhibi...
The gut microbiota metabolite butyrate mitigates MPTP / MPP + ‐induced Parkinson's disease by inhibiting the JAK2 / STAT3 signaling pathway
About this item
Full title
Author / Creator
Publisher
Kaohsiung: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
Kaohsiung: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Butyrate (BU), a gut microbiota‐derived metabolite, has been reported to play a neuroprotective role in Parkinson's disease (PD). However, the specific molecular mechanism of BU has not been fully interpreted. This work aimed to verify the protective effects of BU against MPTP/MPP
+
‐induced neurotoxicity and explore the mechanisms involved....
Alternative Titles
Full title
The gut microbiota metabolite butyrate mitigates MPTP / MPP + ‐induced Parkinson's disease by inhibiting the JAK2 / STAT3 signaling pathway
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_2d731b70c1054d70a51c7db188a12d2b
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2d731b70c1054d70a51c7db188a12d2b
Other Identifiers
ISSN
1607-551X
E-ISSN
2410-8650
DOI
10.1002/kjm2.12745
